NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Monday reported a loss of $11.4 million in its second quarter.

On a per-share basis, the New York-based company said it had a loss of 38 cents.

In the final minutes of trading on Monday, the company's shares hit $2.35. A year ago, they were trading at $6.87.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM